CDC Releases Estimates of Cancer Incidence, Survival for 2011

Share this content:
CDC Releases Estimates of Cancer Incidence, Survival for 2011
CDC Releases Estimates of Cancer Incidence, Survival for 2011

(HealthDay News) -- Estimates of cancer incidence for 2011 in the United States show that about two-thirds of those with cancer survive five or more years after diagnosis, according to a report published in the March 13 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

S. Jane Henley, M.S.P.H., from the CDC in Atlanta, and colleagues analyzed data from U.S. Cancer Statistics for 2011 to assess progress toward achieving Healthy People 2020 objectives.

The researchers found that 1,532,066 invasive cancers were reported to cancer registries in the United States in 2011, for an annual incidence rate of 451 cases per 100,000 persons. The incidence rates were higher among males than females (508 versus 410) and highest among blacks (458). The incidence rates varied by state, from 374 to 509 per 100,000 (339 in Puerto Rico). The proportion of individuals with cancer who survived for five years or more was 65 percent for males and females, but was lower for blacks than whites (60 versus 65 percent).

"Surveillance of cancer incidence and survival are essential for identifying population groups with high cancer incidence rates and low cancer survival rates as well as for estimating the number of cancer survivors, which was 13.7 million in 2012," the authors write. "These data are being used by states to effectively develop comprehensive cancer control programs, including supporting the needs of cancer survivors."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »